Search

everythinglearnresearchcommunity

for

Search:↓

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

A patient lost all their hair while on rheumatoid arthritis medication.

Certain topical drugs can regrow hair in mice.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Ethosomes can effectively deliver drugs deep into the skin, improving treatment for various skin conditions.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Nanoemulgel improves delivery and effectiveness of plant-based drugs for various conditions.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

A patient's grey hair regained color during treatment with adalimumab.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Low dose methotrexate does not increase hair fall and may reduce it.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.